Provider Profile Name: GoodGirl Rx
Legal Name: Good Girl LLC dba GoodGirlRX
Website: goodgirlrx.com
Location: Nashville, TN
Founded: March 2025
Founder: Savannah Chrisley
Provider Type: Telehealth — Virtual Only, Direct-to-Consumer
Operating Details
- Fully virtual — online intake, licensed provider consultation, home delivery
- Insurance pathway available for brand-name medications, or cash-pay option with direct delivery through partner pharmacy network
- No insurance required for cash-pay path
- Free, discreet shipping included
- Medications dispensed by licensed 503A or 503B pharmacy partners; GoodGirl Rx is not the compounder
- No medical director publicly named
Approach GoodGirl Rx describes itself as a wellness company providing science-backed care designed to support the way women actually live, with real providers, physician-prescribed treatments, and affordable care — no insurance required. The platform is targeted specifically at women and positions itself around accessibility, lifestyle alignment, and preventative care — a somewhat differentiated brand angle compared to the clinically neutral framing of most GLP-1 telehealth platforms in this series.
About the Company
GoodGirl Rx was founded by Savannah Chrisley — reality TV personality, Chrisley Knows Best cast member, and host of the Unlocked podcast — and launched in March 2025. The website states it was built on a simple belief that women deserve answers, support, and real solutions that help them feel better from the inside out, and that Chrisley created it to transform the way women understand their health and to make preventative care more accessible to every woman.
The platform’s celebrity-founded status is both its primary marketing asset and the source of its most significant public regulatory event to date.
FDA Warning Letter — February 20, 2026
The FDA sent a warning letter to GoodGirl Rx on February 20, 2026, advising that its website’s claims concerning compounded semaglutide and tirzepatide products were false or misleading under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act.
Specific issues cited by the FDA included: the use of phrases “FDA-approved meds,” “FDA-approved options,” and “clinically proven GLP-1 results” — language the FDA said implied that compounded products had been evaluated for safety and effectiveness when they had not.
Additionally, product images on the website showed the “GoodGirlRX” brand name on the label, suggesting GoodGirl Rx was the compounder of the drugs, when in fact it is not — making the products misbranded under the FDCA.
Chrisley was given 15 business days to correct the issues, otherwise she could face legal consequences for violation of federal law.
Chrisley stated in response: “This was about website wording, not patient safety. There were no fines and no disciplinary action. We’re proud to help women access licensed physicians and we welcome the FDA’s guidance.” The website was updated following the warning, adding disclaimers and changing “clinically proven” to “clinically studied” in relevant marketing copy.
GLP-1 Offerings and Weight Loss Services
GoodGirl Rx offers one of the broader medication menus in this review series:
GLP-1 and Weight Loss Medications:
- Compounded Semaglutide (injectable) — weekly injection via licensed compounding partner
- Compounded Tirzepatide (injectable) — dual GLP-1/GIP receptor agonist
- Semaglutide Microdose and Tirzepatide Microdose — lower-dose options, listed as new offerings
- Brand-name options: Ozempic, Wegovy, Mounjaro, Zepbound — available via insurance pathway or cash pay for eligible patients
Additional Treatments:
- Lipotropic (MIC) + B12 injections, B12, NAD+ injections, NAD+ nasal spray, NAD+ face cream, glutathione, methylene blue, sermorelin injections and tablets
The breadth of the product catalog positions GoodGirl Rx as a full wellness platform rather than a focused GLP-1 weight loss service.
Pricing — and What Reviewers Say
Specific monthly pricing for compounded semaglutide and tirzepatide is not prominently published in third-party sources at the time of writing. Price shown applies to monthly plans paid upfront or with buy now, pay later programs, and actual price will depend on product and plan prescribed — meaning pricing is disclosed after intake rather than before.
Patients considering GoodGirl Rx should request a full cost breakdown including medication, consultation, and shipping before committing to a plan. The availability of both insurance and cash-pay pathways is a meaningful differentiator — patients with qualifying insurance coverage may be able to access brand-name medications at a reduced cost, which most compounded GLP-1 platforms in this series cannot offer.
No large independent patient review pool was identified on Trustpilot, Google, or consumer health platforms for GoodGirl Rx at the time of writing, which limits independent assessment of real-world pricing, shipping reliability, and clinical support quality.
Reviews from Trustpilot and Google
No substantial independent Trustpilot or Google review pool was found for GoodGirl Rx. The platform launched in March 2025 and is relatively new — which combined with a primarily celebrity-influencer-driven marketing channel, means the majority of available testimonials are curated on-site rather than independently verified.
The FDA warning letter, issued less than a year after launch, is the most significant independently verifiable event in GoodGirl Rx’s public record to date. The platform’s response — updating disclaimers and adjusting marketing language — suggests compliance intent, but patients evaluating the platform should consider this regulatory history when making their decision.
Compounding Pharmacies Used
Medications are compounded and dispensed by licensed 503A or 503B pharmacy partners. GoodGirl Rx is not the manufacturer or compounder of these products. Specific pharmacy partner names are not disclosed publicly. The mention of both 503A and 503B sourcing is notable — 503B facilities are FDA-registered and held to cGMP manufacturing standards, while 503A pharmacies operate under state pharmacy board regulation. Patients should ask which type of facility will fulfill their specific prescription.
Note: GoodGirl Rx received an FDA warning letter on February 20, 2026 for false and misleading claims about its compounded semaglutide and tirzepatide products, including the use of phrases suggesting FDA approval that do not apply to compounded drugs. The company updated its website in response. No fines or disciplinary actions were issued. The platform is relatively new (launched March 2025) with limited independent patient reviews. Pricing is not disclosed upfront — request a full cost breakdown before enrolling. Compounded medications are not FDA-approved. Always consult a licensed medical provider before beginning any GLP-1 program.





